By Professor John Philip Chalmers

Journal articles

Wu Y; Huxley R; Li L; Anna V; Xie G; Yao C; Woodward M; Li X; Chalmers J; Gao R; Kong L; Yang X, 2008, 'Prevalence, awareness, treatment, and control of hypertension in China data from the China National Nutrition and Health Survey 2002', Circulation, 118, pp. 2679 - 2686, http://dx.doi.org/10.1161/CIRCULATIONAHA.108.788166

Turnbull F; Woodward M; Neal B; Barzi F; Ninomiya T; Chalmers J; Perkovic V; Li N; MacMahon S; Agodoa L; Anderson C; Asselbergs FW; Baigent C; Black H; Brenner B; Brown M; Bulpitt C; Byington R; Collins R; Cutler J; Dahlof B; Davis B; De Zeeuw D; Dens J; Estacio R; Fagard R; Fox K; Fukui T; Hansson L; Holman R; Hunsicker L; Imai Y; Ishii M; Kanno Y; Kostis J; Kuramoto K; Lewis E; Lièvre M; Lindholm LH; Liu L; Lubsen J; Lueders S; Malacco E; Mancia G; Matsuzaki M; Ohkubo T; Ogihara T; Palmer C; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Poulter N; Rahman M; Remme W; Remuzzi G; Rodgers A; Ruggenenti P; Saruta T; Schrader J; Schrier R; Sever P; Sleight P; Staessen J; Suzuki H; Teo K; Van Gilst WH; Viberti G; Wang J; Whelton P; Wing L; Yui Y; Yusuf S; Zanchetti A, 2008, 'Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials', European Heart Journal, 29, pp. 2669 - 2680, http://dx.doi.org/10.1093/eurheartj/ehn427

Belch J; MacCuish A; Campbell I; Cobbe S; Taylor R; Prescott R; Lee R; Bancroft J; MacEwan S; Shepherd J; Macfarlane P; Morris A; Jung R; Kelly C; Connacher A; Peden N; Jamieson A; Mathews D; Leese G; McKnight J; O'Brien I; Semple C; Petrie J; Gordon D; Pringle S; MacWalter R; Chalmers J; Chalmers J; Doig J; Fraser D; Gray S; Hawthorne V; Lewis S; McCullough D; MacLeod M; Matthews D; Newton R; Reit S; Scott M; Siann T; Smith A; Walker J, 2008, 'The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease', BMJ, 337, pp. 1030 - 1034

Chalmers J; Cooper ME, 2008, 'UKPDS and the legacy effect', New England Journal of Medicine, 359, pp. 1618 - 1620, http://dx.doi.org/10.1056/NEJMe0807625

Patel A; MacMahon S; Chalmers J, 2008, 'Dr. Patel and colleagues reply', New England Journal of Medicine, 359, pp. 1521

Patel A; MacMahon S; Chalmers J, 2008, 'Intensive glucose control in type 2 diabetes - Reply', NEW ENGLAND JOURNAL OF MEDICINE, 359, pp. 1521 - 1521, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259631700020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Perkovic V; Verdon C; Ninomiya T; Barzi F; Cass A; Patel A; Jardine M; Gallagher M; Turnbull F; Chalmers J; Craig J; Huxley R, 2008, 'The relationship between proteinuria and coronary risk: A systematic review and meta-analysis', PLoS Medicine, 5, pp. 1486 - 1495, http://dx.doi.org/10.1371/journal.pmed.0050207

Anderson C; Pogue J; Dyal L; Copland I; Schumacher H; Dagenais G; Sleight P; Ramos B; Richardson L; Murphy J; Haehl M; Hilbrich L; Svaerd R; Martin K; Murwin D; Meinicke T; Schlosser A; Schmidt G; Creek R; Distel M; Aubert B; Schmieder R; Unger T; Asmar R; Mancia G; Diaz R; Paolasso E; Piegas L; Avezum A; Cardona Munoz E; Probstfield J; Weber M; Young J; Fagard R; Jansky P; Mallion J; Mann J; Böhm M; Eber B; Karatzas NB; Keltai M; Trimarco B; Verdecchia P; Maggioni A; Verheugt FWA; Holwerda NJ; Ceremuzynski L; Budaj A; Ferreira R; Chazova I; Rydén L; Svendsen TL; Metsärinne K; Dickstein K; Fodor G; Commerford P; Redon J; Luescher TR; Oto A; Binbrek A; Parkhomenko A; Jennings G; Liu LS; Yu CM; Dans AL; Shah R; Kim JH; Chen JH; Chaithiraphan S; Cairns J; Wilhelmsen L; Chalmers J; Wittes J; Gent M; Hennekens CH; Anderson N; Yusoff K; Auger P; Bernstein V; Panju A; Anand I; Bigger JT; Linz P; Healey J; Held C; McGorrian C; Rokoss M; Villar J; Dans A; Teo K; McDonald A; Schweitzer D; Cunningham J; Wagan E; Boland T; Westfall L; Gulliver N; Oliveira R; McLean-Price C; Kotlan S, 2008, 'Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial', The Lancet, 372, pp. 1174 - 1183, http://dx.doi.org/10.1016/S0140-6736(08)61242-8

Welsh P; Lowe GDO; Chalmers J; Campbell DJ; Rumley A; Neal BC; MacMahon SW; Woodward M, 2008, 'Associations of proinflammatory cytokines with the risk of recurrent stroke', Stroke, 39, pp. 2226 - 2230, http://dx.doi.org/10.1161/STROKEAHA.107.504498

Patel A; MacMahon S; Chalmers J; Neal B; Billot L; Woodward M; Marre M; Cooper M; Glasziou P; Grobbee D; Hamet P; Harrap S; Heller S; Liu L; Mancia G; Mogensen CE; Pan C; Poulter N; Rodgers A; Williams B; Bompoint S; De Galan BE; Joshi R; Travert F, 2008, 'Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes', New England Journal of Medicine, 358, pp. 2560 - 2572, http://dx.doi.org/10.1056/NEJMoa0802987

Yusuf S; Teo KK; Pogue J; Dyal L; Copland I; Schumacher H; Dagenais G; Sleight P; Anderson C; Ramos B; Richardson L; Murphy J; Haehl M; Hilbrich L; Svaerd R; Martin K; Murwin D; Meinicke T; Schlosser A; Schmidt G; Creek R; Schumacher H; Distel M; Aubert B; Pogue J; Schmieder R; Unger T; Asmar R; Mancia G; Diaz R; Paolasso E; Piegas L; Avezum A; Cardona Munoz E; Probstfield J; Weber M; Young J; Fagard R; Jansky P; Mallion J; Mann J; Böhm M; Eber B; Karatzas NB; Keltai M; Trimarco B; Verdecchia P; Maggioni A; Verheugt FWA; Holwerda NJ; Ceremuzynski L; Budaj A; Ferreira R; Chazova I; Rydén L; Svendsen TL; Metsärinne K; Dickstein K; Fodor G; Commerford P; Redon J; Luescher TR; Oto A; Binbrek A; Parkhomenko A; Jennings G; Liu LS; Yu CM; Dans AL; Shah R; Kim JH; Chen JH; Chaithiraphan S; Cairns J; Wilhelmsen L; Chalmers J; Wittes J; Gent M; Hennekens CH; Anderson N; Yusoff K; Auger P; Bernstein V; Panju A; Anand I; Bigger JT; Linz P; Healey J; Held C; McGorrian C; Rokoss M; Villar J; Anderson C; Dans A; Yusuf S; McDonald A; Pogue J; Afzal R, 2008, 'Telmisartan, ramipril, or both in patients at high risk for vascular events', New England Journal of Medicine, 358, pp. 1547 - 1559, http://dx.doi.org/10.1056/NEJMoa0801317

Stolk RP; Van Schooneveld MJ; Cruickshank JK; Hughes AD; Stanton A; Lu J; Patel A; Thom SAMG; Grobbee DE; Vingerling JR, 2008, 'Retinal vascular lesions in patients of caucasian and asian origin with type 2 diabetes', Diabetes Care, 31, pp. 708 - 713, http://dx.doi.org/10.2337/dc07-1657

Chockalingam A; Chalmers J; Whitworth J; Erdine S; Mancia G; Mendis S; Heagerty A, 2008, 'Antalya statement of the International Society of Hypertension on the prevention of blood pressure-related diseases', Journal of Hypertension, 26, pp. 2255 - 2258, http://dx.doi.org/10.1097/HJH.0b013e32831a97ff

Chalmers J; Joshi R; Kengne AP; MacMahon S, 2008, 'Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.', Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 26, http://dx.doi.org/10.1097/01.hjh.0000320754.38732.46

Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A, 2008, 'Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: Results from ADVANCE in context of available evidence', Journal of Hypertension, 26, http://dx.doi.org/10.1097/01.hjh.0000334074.42823.77

Chalmers J; Zanchetti A, 2008, 'Introduction: Advances in the prevention of cardiovascular disease in patients with diabetes', Journal of Hypertension, 26, http://dx.doi.org/10.1097/01.hjh.0000334071.19952.e7

Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A, 2008, 'Efficacité et tolérance de lʼassociation fixe perindopril / indapamide dans le diabète de type 2: résultats de lʼétude ADVANCE', Journal of Hypertension, 26, pp. S23 - S30, http://dx.doi.org/10.1097/01.hjh.0000334603.78628.33

Jamieson F; Chalmers J; Duncan C; Prescott RJ; Campbell IW, 2008, 'Erectile dysfunction in type 1 diabetic males', The British Journal of Diabetes & Vascular Disease, 8, pp. 232 - 234, http://dx.doi.org/10.1177/1474651408094536

Chalmers J; Hunter JE; Robertson SJ; Baird J; Martin M; Franks CI; Whately-Smith CR; Mariz S; Campbell IW, 2007, 'Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes.', Curr Med Res Opin, 23, pp. 1775 - 1781, http://dx.doi.org/10.1185/030079907x210606

Dufouil C; Godin O; Chalmers J; Mazoyer B; MacMahon S; Tzourio-Mazoyer N; Tzourio C, 2006, 'O3–04–08: Effect of white matter lesions on incidence of dementia in patients with stroke', Alzheimer's & Dementia, 2, http://dx.doi.org/10.1016/j.jalz.2006.05.221

Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B, 2005, 'Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack', Stroke, 36, pp. 2164 - 2169, http://dx.doi.org/10.1161/01.str.0000181115.59173.420

Henriksen PA; Lockman KA; Robertson SJ; Clark D; Barclay JI; Chalmers J; Campbell IW, 2004, 'Audit of cardiovascular risk assessment in type 2 diabetic patients referred for insulin therapy: A cardiological perspective', British Journal of Diabetes and Vascular Disease, 4, pp. 34 - 38, http://dx.doi.org/10.1177/14746514040040010601

Chalmers JP; Arnolda LF, 2004, 'Lowering blood pressure in 2003', Medical Journal of Australia, 180, pp. 47 - 47, http://dx.doi.org/10.5694/j.1326-5377.2004.tb05783.x

CHAPMAN N; CHALMERS J, 2003, 'The prevention of secondary stroke, cardiac outcomes and cognitive decline in patients with cerebrovascular disease: The PROGRESS trial*', Seminars in Cerebrovascular Diseases and Stroke, 3, pp. 171 - 180, http://dx.doi.org/10.1053/j.scds.2003.00.027

Chalmers J, 2002, 'The ABCD of anti-hypertensive therapy?', Journal of Hypertension, 20, pp. 615 - 616, http://dx.doi.org/10.1097/00004872-200204000-00016

MacMahon S; Rodgers A; Neal B; Woodward M; Chalmers J, 2001, 'The lowering of blood pressure after stroke - Reply', LANCET, 358, pp. 1994 - 1995, http://dx.doi.org/10.1016/S0140-6736(01)06982-3

Cates C; Upton MN; D'Ambrosio M; Cruickshank J; MacMahon S; Rodgers A; Neal B; Woodward M; Chalmers J; Fournier A; Mazouz H; Choukroun G; Andrejak M; Godefroy O; Staessen JA; Wang JG; Thijs L, 2001, 'The lowering of blood pressure after stroke [1] (multiple letters)', Lancet, 358, pp. 1993 - 1996, http://dx.doi.org/10.1016/S0140-6736(01)06978-1

Chalmers J; Chapman N, 2001, 'Challenges for the prevention of primary and secondary stroke: The importance of lowering blood pressure and total cardiovascular risk', Blood Pressure, 10, pp. 344 - 351, http://dx.doi.org/10.1080/080370501753400647

, 2001, 'Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)', LANCET, 358, pp. 1556 - 1556, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172055800065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

MacMahon S; Neal B; Tzourio C; Rodgers A; Woodward M; Cutler J; Anderson C; Chalmers J; Ohkubo T; Bouser MG; Davis S; Donnan G; Hansson L; Harrap S; Lees KR; Liu L; Mancia G; Omae T; Reid J; Sega R; Terent A; Warlow C; Anderson N; Bladin C; Chambers B; Gordon G; Sharpe N; Collins R; Sandercock P; Simes J; Sleight P; Brnabic A; Colman S; Francis L; Lee A; Gong L; Bousser MG; Yamaguchi T; William F; Deng Q; Hu DX; Wang W; Wu AL; Ma LY; Tao ZY; Biousse V; Berthet K; Ben Slamia L; Le Denmat C; Crespi S; Foglia G; Fujimoto C; Matsumura S; Marttala K; Pettersson M; Safwenberg M; Fenton J; McIlvenna Y; Currie R; Bartram H; Briad J; Clague A; Cleverly Y; Cosson M; Culpan A; Douglas D; Flett S; Gray B; Holloway T; Milne A; Prasad R; Ratnasabapathy Y; Santos A; Wills M; Agnew T; Chapman N; Lewis N; Mullane B, 2001, 'Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack', Lancet, 358, pp. 1033 - 1041, http://dx.doi.org/10.1016/S0140-6736(01)06178-5

Chalmers J; Cooper M; Ferrannini E; Glasziou P; Grobbee D; Hamet P; Harrap S; Liu L; MacMahon S; Mancia G; Marre M; Matthews D; Mogensen C; Neal B; Yu Pan C; Poulter N; Rodgers A; Williams B; Woodward M; Collins R; Sandercock P; Sleight P; Holman R; Fulcher G; Pollock C; Celermajer D; Watson J; Harrisberg B; Currie R; Girgis S; Jayne K; Monaghan H; Patel A; Richens A; Gray B; Milne A; Adderkin A; Bak A; Flett S; De Guise D; Jetses E; Reid J; Stolk R; Wang W; Williams F; Zou X, 2001, 'Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation', Diabetologia, 44, pp. 1118 - 1120, http://dx.doi.org/10.1007/s001250100612

Phillips JK; Goodchild AK; Dubey R; Sesiashvili E; Takeda M; Chalmers J; Pilowsky PM; Lipski J, 2001, 'Differential expression of catecholamine biosynthetic enzymes in the rat ventrolateral medulla', Journal of Comparative Neurology, 432, pp. 20 - 34, http://dx.doi.org/10.1002/cne.1086

Chalmers J; Whitworth JA, 2001, 'A half-century of Australian health and medical research', Medical Journal of Australia, 174, pp. 29 - 32, http://dx.doi.org/10.5694/j.1326-5377.2001.tb143142.x

Chalmers JP, 2001, 'Ongoing trials of angiotensin-converting enzyme inhibition: What they can tell us', American Journal of Hypertension, 14, http://dx.doi.org/10.1016/s0895-7061(01)02153-7

Chalmers J, 2001, 'Rationale and design of the advance study: A randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus', Journal of Hypertension, Supplement, 19

Allan G; Chalmers J; Duncan C; Jones IG; Campbell IW, 2001, 'Audit of mortality in type 2 diabetes mellitus', The British Journal of Diabetes & Vascular Disease, 1, pp. 52 - 54, http://dx.doi.org/10.1177/14746514010010010801

Neal B; MacMahon S; Chapman N; Cutler J; Fagard R; Whelton P; Yusuf S; Agodoa L; Baigent C; Black H; Boissel JP; Brenner B; Brown M; Bulpitt C; Byington R; Chalmers J; Collins R; Dahlof B; Davis B; Estacio R; Fox K; Hansson L; Holman R; Hunsicker L; Kostis J; Kuramoto K; Kusek J; Lees R; Lewis E; Lindholm LH; Liu L; Lubsen J; Malacco E; Mancia G; Martin I; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Remuzzi G; Rodgers A; Ruggenenti P; Schrier R; Sever P; Sleight P; Staessen J; Teo K; Turner R; Wing L; Zanchetti A; Algert C; Woodward M, 2000, 'Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials', Lancet, 356, pp. 1955 - 1964, http://dx.doi.org/10.1016/S0140-6736(00)03307-9

Chockalingam A; Chalmers J; Lisheng L; Labarthe D; MacMahon S; Martin I; Whitworth J, 2000, 'Prevention of cardiovascular diseases in developing countries: Agenda for action, statement from a WHO-ISH meeting in Beijing-October, 1999', CVD Prevention, 3, pp. 255 - 258

Chockalingam A; Balaguer-Vintro I; Achutti A; De Luna AB; Chalmers J; Farinaro E; Lauzon R; Martin I; Papp JG; Postiglione A; Srinath Reddy K; Tse TF, 2000, 'The world heart federation's white book: Impending global pandemic of cardiovascular diseases : Challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition', Canadian Journal of Cardiology, 16, pp. 227 - 229

Chalmers J, 2000, 'Blood pressure burden: Vascular changes and cerebrovascular complications', Journal of Hypertension, Supplement, 18

Chalmers J; Neal B; MacMahon S, 2000, 'PROGRESS (Perindopril Protection Against Recurrent Stroke Study): Regional characteristics of the study population at baseline', Journal of Hypertension, Supplement, 18

Stasinopoulos T; Goodchild AK; Christie MJ; Chalmers J; Pilowsky PM, 2000, 'Delta opioid receptor immunoreactive boutons appose bulbospinal Cl neurons in the rat', NeuroReport, 11, pp. 887 - 891, http://dx.doi.org/10.1097/00001756-200003200-00045

Chalmers J, 2000, 'Global Impact of Stroke', Heart Disease, 2

Chalmers J; Castaigne A; Morgan T; Chastang C, 2000, 'Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients', Journal of Hypertension, 18, pp. 327 - 337, http://dx.doi.org/10.1097/00004872-200018030-00013

Chockalingam A; Chalmers J; Lisheng L; Labarthe D; MacMahon S; Martin I; Whitworth J, 2000, 'Prevention of cardiovascular diseases in developing countries: Agenda for action (Statement from a WHO-ISH meeting in Beijing, October 1999)', Journal of Hypertension, 18, pp. 1705 - 1708, http://dx.doi.org/10.1097/00004872-200018120-00001

Goodchild AK; Van Deurzen BTM; Sun QJ; Chalmers J; Pilowsky PM, 2000, 'Spinal GABA(A) receptors do not mediate the sympathetic baroreceptor reflex in the rat', American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 279, http://dx.doi.org/10.1152/ajpregu.2000.279.1.r320

Chalmers J; Morgan T; Castaigne A, 2000, 'ARE VERY ELDERLY HYPERTENSIVE SUBJECTS (≥75 Y) DIFFERENT FROM ELDERLY SUBJECTS (≥65 Y; <75 Y) FOR A FIXED VERY-LOW-DOSE ACE-INHIBITOR/DIURETIC COMBINATION?', Journal of Hypertension, 18, pp. S98 - S98, http://dx.doi.org/10.1097/00004872-200006001-00328

Llewellyn-Smith IJ; Sun Q; Chalmers J; Cunningham AM; Pilowsky PM, 2000, 'Calbindin-Immunoreactive neurons in the reticular formation of the Rat Brainstem: catecholamine content and spinal projections', Journal of Comparative Neurology, pp. 547 - 562

Chalmers J, 2000, 'Connecting the dots: ongoing ace inhibition trials and what they can tell us Tuesday, may 16, broadway ballroom north, 5:30 pm to 7:30 pm. ace inhibitors: more than just bp reduction', American Journal of Hypertension, 13, pp. S325 - S325, http://dx.doi.org/10.1016/s0895-7061(00)00870-0

Castaigne A; Chalmers J; Morgan T, 2000, 'FIXED VERY-LOW-DOSE COMBINATION PERINDOPRIL 2 mg/INDAPAMIDE 0.625 mg IN THE TREATMENT OF ESSENTIAL ARTERIAL HYPERTENSION IN VERY ELDERLY PATIENTS (±75 YEARS)', Journal of Hypertension, 18, pp. S17 - S17, http://dx.doi.org/10.1097/00004872-200006001-00037

Back to profile page